Oxidative stress and diabetic cardiovascular complications

Free Radical Biology and Medicine

Volumn 40, Issue 2, 2006, Pages 183-192

  Jay, Desmond ^a   Hitomi, Hirofumi ^a   Griendling, Kathy K ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Free radicals

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; 4,5 BIS(4 FLUOROANILINO)PHTHALIMIDE; ADVANCED GLYCATION END PRODUCT; ALDEHYDE REDUCTASE; ALPHA TOCOPHEROL; ASCORBIC ACID; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FATTY ACID; GLITAZONE DERIVATIVE; GLUCOSE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IDITOL DEHYDROGENASE; LEPTIN; N(G),N(G) DIMETHYLARGININE; OXIDIZED LOW DENSITY LIPOPROTEIN; POLYOL; PROBUCOL SUCCINATE; PROTEIN KINASE C INHIBITOR; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE; RUBOXISTAURIN;

ATHEROSCLEROSIS; AUTOOXIDATION; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; DIABETES MELLITUS; DOSE RESPONSE; DRUG EFFECT; ENDOTHELIAL DYSFUNCTION; GLUCOSE OXIDATION; HEART INFARCTION; HUMAN; HYPERGLYCEMIA; MACROPHAGE; META ANALYSIS; MONOCYTE; NONHUMAN; OXIDATIVE STRESS; PERIPHERAL VASCULAR DISEASE; PRIORITY JOURNAL; REVIEW; STROKE; SYSTEMATIC REVIEW; VASCULAR SMOOTH MUSCLE;

ANIMALS; ANTIOXIDANTS; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASES; DIABETES COMPLICATIONS; FREE RADICALS; HUMANS; MODELS, BIOLOGICAL; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES;

ANIMALIA;

EID: 30344486998     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2005.06.018     Document Type: Review

References (124)

1. S. Wild, G. Roglic, A. Green, R. Sicree, and H. King Global prevalence of diabetes: estimates for the year 2000 and projections for 2030 Diabetes Care 27 2004 1047 1053
2. B. Metzger, N.H. Cho, S.M. Roston, and R. Radvany Prepregnancy weight and antepartum insulin secretion predict glucose tolerance five years after gestational diabetes mellitus Diabetes Care 16 1993 1598 1605
3. S. Kjos, R.K. Peters, A. Xiang, O.A. Henry, M. Montoro, and T.A. Buchanan Predicting future diabetes in Latino women with gestational diabetes: utility of early postpartum glucose tolerance testing Diabetes Care 44 1995 586 591
4. J.J. Duby, R.K. Campbell, S.M. Setter, J.R. White, and K.A. Rasmussen Diabetic neuropathy: an intensive review Am. J. Health-Syst. Pharm. 61 2004 160 173
5. E.L. Feldman Oxidative stress and diabetic neuropathy: a new understanding of an old problem J. Clin. Invest. 11 2003 431 433
6. M.A. Yorek The role of oxidative stress in diabetic vascular and neural disease Free Radic. Res. 37 2003 471 480
7. H.B. Lee, M.R. Yu, Y. Yang, Z. Jiang, and H. Ha Reactive oxygen species-regulated signaling pathways in diabetic nephropathy J. Am. Soc. Nephrol. 14 8 Suppl. 3 2003 S241 S245
8. J.M. Li, and A.M. Shah ROS generation by nonphagocytic NADPH oxidase: potential relevance in diabetic nephropathy J. Am. Soc. Nephrol. 14 8 Suppl. 3 2003 S221 S226
9. Centers for Disease Control and Prevention National diabetes fact sheet: general information and national estimates on diabetes in the United States, 2003 2004 U.S. Department of Health and Human Services, Centers for Disease Control and Prevention Atlanta, GA
10. R.D. Abbott, R.P. Kannel, and W.B. Wilson The impact of diabetes on survival following myocardial infarction in men vs women: the Framingham Study JAMA 260 1988 3456 3460
11. J.K. Herlitz, B.W. Edrardsson, N. Emanuelsson, and H. Hjalmarson Prognosis in diabetics with chest pain or other symptoms suggestive of acute myocardial infarction Cardiology 80 1992 237 245
12. H.L. Miettinen, S. Salomaa, V. Mähönen, M. Niemelä, M. Haffner, M. Pyörälä, K. Tuomilehto for the FINMONICA Myocardial Infarction Register Study Group Impact of diabetes on mortality after the first myocardial infarction Diabetes Care 21 1998 69 75
13. K. Jamrozik, R.J. Broadhurst, S. Forbes, G.J. Hankey, and C.S. Anderson Predictors of death and vascular events in the elderly: the Perth Community Stroke Study Stroke 31 2000 863 868
14. A.R. Folsom, M.L. Rasmussen, L.E. Chambless, G. Howard, L.S. Cooper, M.I. Schmidt, and G. Heiss Prospective associations of fasting insulin, body fat distribution, and diabetes with risk of ischemic stroke. The Atherosclerosis Risk in Communities (ARIC) Study Investigators Diabetes Care 22 1999 1077 1083
15. F. Hu, M. Stampfer, C. Solomon, W. Willett, and J. Manson Diabetes mellitus and mortality from all causes and coronary heart disease in women: 20 years of follow-up Diabetes 49 Suppl. 1 2000 A20
16. S. Haffner, R.J. D'Agostino, M. Saad, D. O'Leary, P. Savage, M. Rewers, J. Selby, R. Bergman, and L. Mykkänen Carotid artery atherosclerosis in type-2 diabetic and nondiabetic subjects with and without symptomatic coronary artery disease: the Insulin Resistance Atherosclerosis Study Am. J. Cardiol. 85 2000 1395 1400
17. S. Haffner, S. Lehto, T. Rönnemaa, K. Pyörälä, and M. Laakso Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction N. Engl. J. Med. 339 1998 229 234
18. K. Malmberg, S. Yusuf, H. Gerstein, J. Brown, F. Zhao, D. Hunt, L. Piegas, J. Calvin, M. Keltai, A. Budaj for the OASIS Registry Investigators Impact of diabetes on long-term prognosis in patients with unstable angina and non-Q-wave myocardial infarction: results of the OASIS (Organization to Assess Strategies for Ischemic Syndromes) Registry Circulation 102 2000 1014 1019
19. P. Martin-Gallan, A. Carrascosa, M. Gussinye, and C. Dominguez Biomarkers of diabetes-associated oxidative stress and antioxidant status in young diabetic patients with or without subclinical complications Free Radic. Biol. Med. 34 2003 1563 1574
20. J. Varvarovska, J. Racek, F. Stozicky, J. Soucek, L. Trefil, and R. Pomahacova Parameters of oxidative stress in children with type 1 diabetes mellitus and their relatives J. Diabetes Complications 17 2003 7 10
21. I. Seghrouchni, J. Drai, E. Bannier, J. Riviere, P. Calmard, I. Garcia, J. Orgiazzi, and A. Revol Oxidative stress parameters in type I, type II and insulin-treated type 2 diabetes mellitus; insulin treatment efficiency Clin. Chim. Acta 321 2002 89 96
22. D.J. Vander Jagt, J.M. Harrison, D.M. Ratliff, L.A. Hunsaker, and D.L. Vander Jagt Oxidative stress indices in IDDM subjects with and without long-term diabetic complications Clin. Biochem. 34 2001 265 270
23. D. Bonnefont-Rousselot Glucose and reactive oxygen species Curr. Opin. Clin. Nutr. Metab. Care 5 2002 561 568
24. A. Ceriello, and E. Motz Is oxidative stress the pathogenic mechanism underlying insulin resistance, diabetes, and cardiovascular disease? The common soil hypothesis revisited Arterioscler. Thromb. Vasc. Biol. 24 2004 816 823
25. T. Nishikawa, D. Edelstein, X.L. Du, S. Yamagishi, T. Matsumura, Y. Kaneda, M.A. Yorek, D. Beebe, P.J. Oates, H.P. Hammes, I. Giardino, and M. Brownlee Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage Nature 404 2000 787 790
26. T. Inoguchi, P. Li, F. Umeda, H.Y. Yu, M. Kakimoto, M. Imamura, T. Aoki, T. Etoh, T. Hashimoto, M. Naruse, H. Sano, H. Utsumi, and H. Nawata High glucose level and free fatty acid stimulate reactive oxygen species production through protein kinase C-dependent activation of NAD(P)H oxidase in cultured vascular cells Diabetes 49 2000 1939 1945
27. G. Basta, A.M. Schmidt, and R. De Caterina Advanced glycation end products and vascular inflammation: implications for accelerated atherosclerosis in diabetes Cardiovasc. Res. 63 2004 582 592
28. Y. Nakamura, Y. Horii, T. Nishino, H. Shiiki, Y. Sakaguchi, T. Kagoshima, K. Dohi, Z. Makita, H. Vlassara, and R. Bucala Immunohistochemical localization of advanced glycosylation end products in coronary atheroma and cardiac tissue in diabetes mellitus Am. J. Pathol. 143 1993 1649 1656
29. S.D. Yan, A.M. Schmidt, G.M. Anderson, J. Zhang, J. Brett, Y.S. Zou, D. Pinsky, and D. Stern Enhanced cellular oxidant stress by the interaction of advanced glycation end products with their receptors/binding proteins J. Biol. Chem. 269 1994 9889 9897
30. M.P. Wautier, O. Chappey, S. Corda, D.M. Stern, A.M. Schmidt, and J.L. Wautier Activation of NADPH oxidase by AGE links oxidant stress to altered gene expression via RAGE Am. J. Physiol. Endocrinol. Metab. 280 2001 E685 E694
31. A.M. Schmidt, O. Hori, J.X. Chen, J.F. Li, J. Crandall, J. Zhang, R. Cao, S.D. Yan, J. Brett, and D. Stern Advanced glycation endproducts interacting with their endothelial receptor induce expression of vascular cell adhesion molecule-1 (VCAM-1) in cultured human endothelial cells and in mice: a potential mechanism for the accelerated vasculopathy of diabetes J. Clin. Invest. 96 1995 1395 1403
32. N.F. Chu, D. Spiegelman, G.S. Hotamisligil, N. Rifai, M. Stampfer, and E.B. Rimm Plasma insulin, leptin, and soluble TNF receptors levels in relation to obesity-related atherogenic and thrombogenic cardiovascular disease risk factors among men Atherosclerosis 157 2001 495 503
33. K.V. Ramana, D. Chandra, S. Srivastava, A. Bhatnagar, and S.K. Srivastava Nitric oxide regulates the polyol pathway of glucose metabolism in vascular smooth muscle cells FASEB J. 17 2003 417 425
34. D.M. Morre, G. Lenaz, and D.J. Morre Surface oxidase and oxidative stress propagation in aging J. Exp. Biol. 203 Pt. 10 2000 1513 1521
35. H. Steinberg, and A. Baron Vascular function, insulin resistance and fatty acids Diabetologia 45 2002 623 634
36. H.F. Lopes, J.D. Morrow, M.P. Stojiljkovic, T.L. Goodfriend, and B.M. Egan Acute hyperlipidemia increases oxidative stress more in African Americans than in white Americans Am. J. Hypertens 16 5 Pt. 1 2003 331 336
37. M.P. Stojiljkovic, H.F. Lopes, D. Zhang, J.D. Morrow, T.L. Goodfriend, and B.M. Egan Increasing plasma fatty acids elevates F2-isoprostanes in humans: implications for the cardiovascular risk factor cluster J. Hypertens. 20 2002 1215 1221
38. F. Peelman, W. Waelput, H. Iserentant, D. Lavens, S. Eyckerman, L. Zabeau, and J. Tavernier Leptin: linking adipocyte metabolism with cardiovascular and autoimmune diseases Prog. Lipid Res. 43 2004 283 301
39. W.B. Chan, R.C. Ma, N.N. Chan, M.C. Ng, Z.S. Lee, C.W. Lai, P.C. Tong, W.Y. So, and J.C. Chan Increased leptin concentrations and lack of gender difference in type 2 diabetic patients with nephropathy Diabetes Res. Clin. Pract. 64 2004 93 98
40. M. Wauters, R.V. Considine, J.S. Yudkin, F. Peiffer, I. De Leeuw, and L.F. Van Gaal Leptin levels in type 2 diabetes: associations with measures of insulin resistance and insulin secretion Horm. Metab. Res. 35 2003 92 96
41. M.P. Reilly, N. Iqbal, M. Schutta, M.L. Wolfe, M. Scally, A.R. Localio, D.J. Rader, and S.E. Kimmel Plasma leptin levels are associated with coronary atherosclerosis in type 2 diabetes J. Clin. Endocrinol. Metab. 89 2004 3872 3878
42. S.I. Yamagishi, D. Edelstein, X.L. Du, Y. Kaneda, M. Guzman, and M. Brownlee Leptin induces mitochondrial superoxide production and monocyte chemoattractant protein-1 expression in aortic endothelial cells by increasing fatty acid oxidation via protein kinase A J. Biol. Chem. 276 2001 25096 25100
43. A. Bouloumie, T. Marumo, M. Lafontan, and R. Busse Leptin induces oxidative stress in human endothelial cells FASEB J. 13 1999 1231 1238
44. G.M. Chisolm, and D. Steinberg The oxidative modification hypothesis of atherogenesis: an overview Free Radic. Biol. Med. 28 2000 1815 1826
45. R. Ross Atherosclerosis-an inflammatory disease N. Engl. J. Med. 340 2004 115 126
46. A. Liguori, P. Abete, J.M. Hayden, F. Cacciatore, F. Rengo, G. Ambrosio, D. Bonaduce, M. Condorelli, P.D. Reaven, and C. Napoli Effect of glycaemic control and age on low-density lipoprotein susceptibility to oxidation in diabetes mellitus type 1 Eur. Heart J. 22 2001 2075 2084
47. L. MacDonald-Wicks, L.Z. Gibson, D.M. Godfrey, J.M. Green, B.P. Horan, K.L. Monger, R.M. Wischer, and M.L. Garg Oxidised LDL in newly diagnosed type 2 diabetes mellitus and impaired glucose tolerance Asia Pac. J. Clin. Nutr. 13 2004 S65 (Suppl.)
48. A. Ceriello, N. Bortolotti, E. Motz, C. Pieri, M. Marra, L. Tonutti, S. Lizzio, F. Feletto, B. Catone, and C. Taboga Meal-induced oxidative stress and low-density lipoprotein oxidation in diabetes: the possible role of hyperglycemia Metab. Clin. Exp. 48 1999 1503 1508
49. A. Kondo, M. Manabe, K. Saito, M. Maekawa, and T. Kanno Insulin treatment prevents LDL from accelerated oxidation in patients with diabetes J. Atheroscler. Thromb. 9 2002 280 287
50. K. Williams, and I. Tabas The response-to-retention hypothesis of early atherogenesis Arterioscler. Thromb. Vasc. Biol. 15 1995 551 561
51. T.J. Guzik, S. Mussa, D. Gastaldi, J. Sadowski, C. Ratnatunga, R. Pillai, and K.M. Channon Mechanisms of increased vascular superoxide production in human diabetes mellitus: role of NAD(P)H oxidase and endothelial nitric oxide synthase Circulation 105 2002 1656 1662
52. K. Kornerup, B.G. Nordestgaard, B. Feldt-Rasmussen, K. Borch-Johnsen, K.S. Jensen, and J.S. Jensen Increased transvascular low density lipoprotein transport in insulin dependent diabetes: a mechanistic model for development of atherosclerosis Atherosclerosis 170 2003 163 168
53. H.M. Knott, B.E. Brown, M.J. Davies, and R.T. Dean Glycation and glycoxidation of low-density lipoproteins by glucose and low-molecular mass aldehydes: formation of modified and oxidized particles Eur. J. Biochem. 270 2003 3572 3582
54. P. Nivoit, N. Wiernsperger, P. Moulin, M. Lagarde, and C. Renaudin Effect of glycated LDL on microvascular tone in mice: a comparative study with LDL modified in vitro or isolated from diabetic patients Diabetologia 46 2003 1550 1558
55. R.W. O'Donnell, D.K. Johnson, L.M. Ziegler, A.J. DiMattina, R.I. Stone, and J.A. Holland Endothelial NADPH oxidase: mechanism of activation by low-density lipoprotein J. Endothelial. Cell Res. 10 2003 291 297
56. L. Li, T. Sawamura, and G. Renier Glucose enhances endothelial LOX-1 expression: role for LOX-1 in glucose-induced human monocyte adhesion to endothelium Diabetes 52 2003 1843 1850
57. L. Li, T. Sawamura, and G. Renier Glucose enhances human macrophage LOX-1 expression: role for LOX-1 in glucose-induced macrophage foam cell formation Circ. Res. 94 2004 892 901
58. M.J. Jarvisalo, M. Raitakari, J.O. Toikka, A. Putto-Laurila, R. Rontu, S. Laine, T. Lehtimaki, T. Ronnemaa, J. Viikari, and O.T. Raitakari Endothelial dysfunction and increased arterial intima-media thickness in children with type 1 diabetes Circulation 109 2004 1750 1755
59. A. Koitka, P. Abraham, B. Bouhanick, D. Sigaudo-Roussel, C. Demiot, and J.L. Saumet Impaired pressure-induced vasodilation at the foot in young adults with type 1 diabetes Diabetes 53 2004 721 725
60. G.I. Papaioannou, R.L. Seip, N.J. Grey, D. Katten, A. Taylor, S.E. Inzucchi, L.H. Young, D.A. Chyun, J.A. Davey, F.J. Wackers, A.E. Iskandrian, R.E. Ratner, E.C. Robinson, S. Carolan, S. Engel, and G.V. Heller Brachial artery reactivity in asymptomatic patients with type 2 diabetes mellitus and microalbuminuria (from the Detection of Ischemia in Asymptomatic Diabetics-Brachial Artery Reactivity Study) Am. J. Cardiol. 94 2004 294 299
61. D. Rizzoni, E. Porteri, D. Guelfi, M.L. Muiesan, A. Piccoli, U. Valentini, A. Cimino, A. Girelli, M. Salvetti, C. De Ciuceis, G.A. Tiberio, S.M. Giulini, I. Sleiman, C. Monteduro, and E.A. Rosei Endothelial dysfunction in small resistance arteries of patients with non-insulin-dependent diabetes mellitus J. Hypertens. 19 2001 913 919
62. R.A. Skyrme-Jones, R.C. O'Brien, K.L. Berry, and I.T. Meredith Vitamin E supplementation improves endothelial function in type I diabetes mellitus: a randomized, placebo-controlled study J. Am. Coll. Cardiol. 36 2000 94 102
63. G.M. Pieper, and W. Siebeneich Oral administration of the antioxidant, N-acetylcysteine, abrogates diabetes-induced endothelial dysfunction J. Cardiovasc. Pharmacol. 32 1998 101 105
64. T. Inoguchi, T. Sonta, H. Tsubouchi, T. Etoh, M. Kakimoto, N. Sonoda, N. Sato, N. Sekiguchi, K. Kobayashi, H. Sumimoto, H. Utsumi, and H. Nawata Protein kinase C-dependent increase in reactive oxygen species (ROS) production in vascular tissues of diabetes: role of vascular NAD(P)H oxidase J. Am. Soc. Nephrol. 14 8 Suppl. 3 2003 S227 S232
65. S. Milstien, and Z. Katusic Oxidation of tetrahydrobiopterin by peroxynitrite: implications for vascular endothelial function Biochem. Biophys. Res. Commun. 263 1999 681 684
66. W. Kossenjans, A. Eis, R. Sahay, D. Brockman, and L. Myatt Role of peroxynitrite in altered fetal-placental vascular reactivity in diabetes or preeclampsia Am. J. Physiol. Heart Circ. Physiol. 278 2000 H1311 H1319
67. J. Vasquez-Vivar, B. Kalyanaraman, P. Martasek, N. Hogg, B. Masters, H. Karoui, P. Tordo, and K. Pritchard Jr. Superoxide generation by endothelial nitric oxide synthase: the influence of cofactors Proc. Natl. Acad. Sci. USA 95 1998 9220 9225
68. 2+/calmodulin-dependent and tetrahydrobiopterin regulatory process J. Biol. Chem. 273 1998 25804 25808
69. C.J. Meininger, R.S. Marinos, K. Hatakeyama, R. Martinez-Zaguilan, J.D. Rojas, K.A. Kelly, and G. Wu Impaired nitric oxide production in coronary endothelial cells of the spontaneously diabetic BB rat is due to tetrahydrobiopterin deficiency Biochem. J. 349 Pt. 1 2000 353 356
70. N.J. Alp, S. Mussa, J. Khoo, S. Cai, T. Guzik, A. Jefferson, N. Goh, K.A. Rockett, and K.M. Channon Tetrahydrobiopterin-dependent preservation of nitric oxide-mediated endothelial function in diabetes by targeted transgenic GTP-cyclohydrolase I overexpression J. Clin. Invest. 112 2003 725 735
71. T. Heitzer, K. Krohn, S. Albers, and T. Meinertz Tetrahydrobiopterin improves endothelium-dependent vasodilation by increasing nitric oxide activity in patients with type II diabetes mellitus Diabetologia 43 2000 1435 1438
72. X.L. Du, D. Edelstein, S. Dimmeler, Q. Ju, C. Sui, and M. Brownlee Hyperglycemia inhibits endothelial nitric oxide synthase activity by posttranslational modification at the Akt site J. Clin. Invest. 108 2001 1341 1348
73. R. Potashnik, A. Bloch-Damti, N. Bashan, and A. Rudich IRS1 degradation and increased serine phosphorylation cannot predict the degree of metabolic insulin resistance induced by oxidative stress Diabetologia 46 2003 639 648
74. K.Y. Lin, A. Ito, T. Asagami, P.S. Tsao, S. Adimoolam, M. Kimoto, H. Tsuji, G.M. Reaven, and J.P. Cooke Impaired nitric oxide synthase pathway in diabetes mellitus: role of asymmetric dimethylarginine and dimethylarginine dimethylaminohydrolase Circulation 106 2002 987 992
75. H. Takaishi, T. Taniguchi, A. Takahashi, Y. Ishikawa, and M. Yokoyama High glucose accelerates MCP-1 production via p38 MAPK in vascular endothelial cells Biochem. Biophys. Res. Commun. 305 2003 122 128
76. S. Srinivasan, M. Yeh, E.C. Danziger, M.E. Hatley, A.E. Riggan, N. Leitinger, J.A. Berliner, and C.C. Hedrick Glucose regulates monocyte adhesion through endothelial production of interleukin-8 Circ. Res. 92 2003 371 377
77. S. Uemura, H. Matsushita, W. Li, A.J. Glassford, T. Asagami, K.H. Lee, D.G. Harrison, and P.S. Tsao Diabetes mellitus enhances vascular matrix metalloproteinase activity: role of oxidative stress Circ. Res. 88 2001 1291 1298
78. F. Curcio, I. Pegoraro, P. Dello Russo, E. Falleti, G. Perrella, and A. Ceriello SOD and GSH inhibit the high glucose-induced oxidative damage and the PDGF increased secretion in cultured human endothelial cells Thromb. Haemostasis 74 1995 969 973
79. A. Ceriello, F. Curcio, P. dello Russo, I. Pegoraro, G. Stel, P. Amstad, and P. Cerutti The defence against free radicals protects endothelial cells from hyperglycaemia-induced plasminogen activator inhibitor 1 over-production Blood Coagul. Fibrinolysis 6 1995 133 137
80. D. Tripathy, P. Mohanty, S. Dhindsa, T. Syed, H. Ghanim, A. Aljada, and P. Dandona Elevation of free fatty acids induces inflammation and impairs vascular reactivity in healthy subjects Diabetes 52 2003 2882 2887
81. J.L. Wautier, C. Zoukourian, O. Chappey, M.P. Wautier, P.J. Guillausseau, R. Cao, O. Hori, D. Stern, and A.M. Schmidt Receptor-mediated endothelial cell dysfunction in diabetic vasculopathy: soluble receptor for advanced glycation end products blocks hyperpermeability in diabetic rats J. Clin. Invest. 97 1996 238 243
82. Y. Wen, J.C. Skidmore, M.M. Porter-Turner, C.A. Rea, M.A. Khokher, and B.M. Singh Relationship of glycation, antioxidant status and oxidative stress to vascular endothelial damage in diabetes Diabetes Obes. Metab. 4 2002 305 308
83. G. De Mattia, M.C. Bravi, O. Laurenti, M. Cassone-Faldetta, A. Proietti, O. De Luca, A. Armiento, and C. Ferri Reduction of oxidative stress by oral N-acetyl-l-cysteine treatment decreases plasma soluble vascular cell adhesion molecule-1 concentrations in non-obese, non-dyslipidaemic, normotensive, patients with non-insulin-dependent diabetes Diabetologia 41 1998 1392 1396
84. J. Pleiner, G. Schaller, F. Mittermayer, M. Bayerle-Eder, M. Roden, and M. Wolzt FFA-induced endothelial dysfunction can be corrected by vitamin C J. Clin. Endocrinol. Metab. 87 2002 2913 2917
85. S. Dhindsa, D. Tripathy, P. Mohanty, H. Ghanim, T. Syed, A. Aljada, and P. Dandona Differential effects of glucose and alcohol on reactive oxygen species generation and intranuclear nuclear factor-kappaB in mononuclear cells Metab. Clin. Exp. 53 2004 330 334
86. S.K. Venugopal, S. Devaraj, T. Yang, and I. Jialal Alpha-tocopherol decreases superoxide anion release in human monocytes under hyperglycemic conditions via inhibition of protein kinase C-alpha Diabetes 51 2002 3049 3054
87. M.A. Hofmann, S. Schiekofer, M. Kanitz, M.S. Klevesath, M. Joswig, V. Lee, M. Morcos, H. Tritschler, R. Ziegler, P. Wahl, A. Bierhaus, and P.P. Nawroth Insufficient glycemic control increases nuclear factor-kappa B binding activity in peripheral blood mononuclear cells isolated from patients with type 1 diabetes Diabetes Care 21 1998 1310 1316
88. M. Guha, W. Bai, J.L. Nadler, and R. Natarajan Molecular mechanisms of tumor necrosis factor alpha gene expression in monocytic cells via hyperglycemia-induced oxidant stress-dependent and -independent pathways J. Biol. Chem. 275 2000 17728 17739
89. C. Viedt, U. Soto, H.I. Krieger-Brauer, J. Fei, C. Elsing, W. Kubler, and J. Kreuzer Differential activation of mitogen-activated protein kinases in smooth muscle cells by angiotensin II: involvement of p22phox and reactive oxygen species Arterioscler. Thromb. Vasc. Biol. 20 2000 940 948
90. M.P. Cohen, E. Shea, S. Chen, and C.W. Shearman Glycated albumin increases oxidative stress, activates NF-kappa B and extracellular signal-regulated kinase (ERK), and stimulates ERK-dependent transforming growth factor-beta 1 production in macrophage RAW cells J. Lab. Clin. Med. 141 2003 242 249
91. M.C. Beauchamp, S.E. Michaud, L. Li, M.R. Sartippour, and G. Renier Advanced glycation end products potentiate the stimulatory effect of glucose on macrophage lipoprotein lipase expression J. Lipid Res. 45 2004 1749 1757
92. S. Willliams, J. Cusco, M. Roddy, M. Johnstone, and M. Creager Impaired nitric oxide-mediated vasodilation in patients with non-insulin-dependent diabetes mellitus J. Am. Coll. Cardiol. 27 1996 567 574
93. H.S. Lee, S.M. Son, Y.K. Kim, K.W. Hong, and C.D. Kim NAD(P)H oxidase participates in the signaling events in high glucose-induced proliferation of vascular smooth muscle cells Life Sci. 72 2003 2719 2730
94. R. Muniyappa, P.R. Srinivas, J.L. Ram, M.F. Walsh, and J.R. Sowers Calcium and protein kinase C mediate high-glucose-induced inhibition of inducible nitric oxide synthase in vascular smooth muscle cells Hypertension 31 1 Pt. 2 1998 289 295
95. L.A. Suzuki, M. Poot, R.G. Gerrity, and K.E. Bornfeldt Diabetes accelerates smooth muscle accumulation in lesions of atherosclerosis: lack of direct growth-promoting effects of high glucose levels Diabetes 50 2001 851 860
96. H.Y. Jeong, and C.D. Kim p22phox-derived superoxide mediates enhanced proliferative capacity of diabetic vascular smooth muscle cells Diabetes Res. Clin. Pract. 64 2004 1 10
97. K.V. Ramana, B. Friedrich, S. Srivastava, A. Bhatnagar, and S.K. Srivastava Activation of nuclear factor-kappaB by hyperglycemia in vascular smooth muscle cells is regulated by aldose reductase Diabetes 53 2004 2910 2920
98. Y. Kasuya, J. Nakamura, Y. Hamada, M. Nakayama, H. Sasaki, T. Komori, S. Chaya, G. Watanabe, K. Naruse, E. Nakashima, K. Kato, and N. Hotta An aldose reductase inhibitor prevents the glucose-induced increase in PDGF-beta receptor in cultured rat aortic smooth muscle cells Biochem. Biophys. Res. Commun. 261 1999 853 858
99. U. Garg, and A. Hassid Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells J. Clin. Invest. 83 1989 1774 1777
100. H. Fukumoto, Z. Naito, G. Asano, and T. Aramaki Immunohistochemical and morphometric evaluations of coronary atherosclerotic plaques associated with myocardial infarction and diabetes mellitus J. Atheroscler. Thromb. 5 1998 29 35
101. C. Peiro, N. Lafuente, N. Matesanz, E. Cercas, J.L. Llergo, S. Vallejo, L. Rodriguez-Manas, and C.F. Sanchez-Ferrer High glucose induces cell death of cultured human aortic smooth muscle cells through the formation of hydrogen peroxide Br. J. Pharmacol. 133 2001 967 974
102. C.C. Hsieh, M.H. Yen, C.H. Yen, and Y.T. Lau Oxidized low density lipoprotein induces apoptosis via generation of reactive oxygen species in vascular smooth muscle cells Cardiovasc. Res. 49 2001 135 145
103. Heart Protection Study Collaborative MRC/BHF heart protection study of antioxidant vitamin supplementation in 20,536 high-risk individuals: a randomised placebo-controlled trial Lancet 360 2002 23 33
104. E. Lonn, S. Yusuf, B. Hoogwerf, J. Pogue, Q. Yi, B. Zinman, J. Bosch, G. Dagenais, J.F. Mann, H.C. Gerstein, H. Study, and M.-H. Study Effects of vitamin E on cardiovascular and microvascular outcomes in high-risk patients with diabetes: results of the HOPE study and MICRO-HOPE substudy Diabetes Care 25 2002 1919 1927
105. E.R. Miller III, R. Pastor-Barriuso, D. Dalal, R.A. Riemersma, L.J. Appel, and E. Guallar Meta-analysis: high-dosage vitamin E supplementation may increase all-cause mortality Ann. Intern. Med. 142 2005 37 46
106. F. Violi, L. Loffredo, L. Musella, and A. Marcoccia Should antioxidant status be considered in interventional trials with antioxidants? Heart 90 2004 598 602
107. K.K. Griendling, and G.A. FitzGerald Oxidative stress and cardiovascular injury. Part II. Animal and human studies Circulation 108 2003 2034 2040
108. F. Violi, F. Micheletta, and L. Iuliano How to select patient candidates for antioxidant treatment Circulation 106 2002 e195 [Author reply p. e195]
109. M. Reilly, N. Delanty, J. Lawson, and G. FitzGerald Modulation of oxidant stress in vivo in chronic cigarette smokers Circulation 94 1996 19 25
110. E. Meagher, O. Barry, A. Burke, M. Lucey, J. Lawson, J. Rokach, and G. FitzGerald Alcohol-induced generation of lipid peroxidation products in humans J. Clin. Invest. 104 1999 805 813
111. G. McGregor Vitamin C contributes to inflammation via radical generating mechanisms: a cautionary note Med. Hypotheses 62 2004 641 642
112. J. Upston, A. Terentis, K. Morris, J.J. Keaney, and R. Stocker Oxidized lipid accumulates in the presence of alpha-tocopherol in atherosclerosis Biochem. J. 363 Pt. 3 2002 753 760
113. J.C. Tardif, J. Gregoire, M.A. Lavoie, and P.L. L'Allier Pharmacologic prevention of both restenosis and atherosclerosis progression: AGI-1067, probucol, statins, folic acid and other therapies Curr. Opin. Lipidol. 14 2003 615 620
114. J.C. Tardif Clinical results with AGI-1067: a novel antioxidant vascular protectant Am. J. Cardiol. 91 2003 41A 49A
115. J.C. Tardif, J. Gregoire, L. Schwartz, L. Title, L. Laramee, F. Reeves, J. Lesperance, M.G. Bourassa, P.L. L'Allier, M. Glass, J. Lambert, and M.C. Guertin Canadian Antioxidant Restenosis Trial. I. Effects of AGI-1067 and probucol after percutaneous coronary interventions Circulation 107 2003 552 558
116. R. Collins, J. Armitage, S. Parish, P. Sleigh, R. Peto Heart Protection Study Collaborative MRC/BHF heart protection study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial Lancet 361 2003 2005 2016
117. U. Rueckschloss, J. Galle, J. Holtz, H.R. Zerkowski, and H. Morawietz Induction of NAD(P)H oxidase by oxidized low-density lipoprotein in human endothelial cells: antioxidative potential of hydroxymethylglutaryl coenzyme A reductase inhibitor therapy Circulation 104 2001 1767 1772
118. R.P. Mason, M.F. Walter, and R.F. Jacob Effects of HMG-CoA reductase inhibitors on endothelial function: role of microdomains and oxidative stress Circulation 109 21 Suppl. 1 2004 II34 II41
119. B. Charbonnel, J. Dormandy, E. Erdmann, M. Massi-Benedetti, A. Skene, and P.R.S. Group The prospective pioglitazone clinical trial in macrovascular events (PROactive): can pioglitazone reduce cardiovascular events in diabetes? Study design and baseline characteristics of 5238 patients Diabetes Care 27 2004 1647 1653
120. H. Yki-Jarvinen Thiazolidinediones N. Engl. J. Med. 351 2004 1106 1118
121. L.G. Bucciarelli, T. Wendt, W. Qu, Y. Lu, E. Lalla, L.L. Rong, M.T. Goova, B. Moser, T. Kislinger, D.C. Lee, Y. Kashyap, D.M. Stern, and A.M. Schmidt RAGE blockade stabilizes established atherosclerosis in diabetic apolipoprotein E-null mice Circulation 106 2002 2827 2835
122. A. Kouroedov, M. Eto, H. Joch, M. Volpe, T.F. Luscher, and F. Cosentino Selective inhibition of protein kinase Cβ2 prevents acute effects of high glucose on vascular cell adhesion molecule-1 expression in human endothelial cells Circulation 110 2004 91 96
123. J. Carlsson, E.B. Kullberg, J. Capala, S. Sjoberg, K. Edwards, and L. Gedda Ligand liposomes and boron neutron capture therapy J. Neuro-Oncol. 62 2003 47 59
124. Y. Hattori, and Y. Maitani Enhanced in vitro DNA transfection efficiency by novel folate-linked nanoparticles in human prostate cancer and oral cancer J. Controlled Release 97 2004 173 183